Evaluation of Treatment Outcomes With Palatal Plate Versus Conventional Tooth Borne Anchorage in Class III Patients

evaluation of treatment outcomes with palatal plate versus conventional tooth borne anchorage in class III patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Skeletal Class III Malocclusion

Age range

9 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Dentistry , Al Azhar University, Girls Branch, Cairo

Cairo, Egypt

About this study

group (A) patients were treated with transpalatal arch and facemask. group(B) patients were treated by palatal plate and facemask

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

skeletal class III malocclusion deficient maxilla+ growing patient

Exclusion criteria

adult patient, cleft patient

Treatment and study plan

treatment of skeletal class III by maxillary advancement using transpalatal arch and face mask

Device

TPA group

treatment of skeletal class III by maxillary advancement using palatal plate and face mask

Device

palatal plate group

Primary outcomes

skeletal and dental maxillary changes including SN angle, SNB angle, ANB angle

Time frame: 3-12 months

lateral cephalometry

Sponsors and collaborators

Lead sponsor

Faculty of Dental Medicine for Girls

Other Gov

Registry information

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Jan 22, 2026
Registry last updated: Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed